(NASDAQ: SEER) Seer's forecast annual revenue growth rate of 23.48% is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 106.08%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 24.86%.
Seer's revenue in 2025 is $16,288,000.On average, 3 Wall Street analysts forecast SEER's revenue for 2025 to be $1,005,657,201, with the lowest SEER revenue forecast at $966,219,664, and the highest SEER revenue forecast at $1,035,235,354. On average, 3 Wall Street analysts forecast SEER's revenue for 2026 to be $1,247,014,929, with the lowest SEER revenue forecast at $1,198,112,383, and the highest SEER revenue forecast at $1,283,691,839.
In 2027, SEER is forecast to generate $1,775,703,287 in revenue, with the lowest revenue forecast at $1,706,067,864 and the highest revenue forecast at $1,827,929,854.